{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:30:42Z","timestamp":1790289042517,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00392-018-1387-z","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T10:22:53Z","timestamp":1540549373000},"page":"612-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction"],"prefix":"10.1007","volume":"108","author":[{"given":"Hilde E.","family":"Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawien","family":"Al Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwan C. C.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco A. J.","family":"Schurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hindrik W.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lipsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco C.","family":"Karper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"1387_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","volume":"2","author":"DJ Benjamin","year":"2018","unstructured":"Benjamin DJ, Berger JO, Johannesson M (2018) Redefine statistical significance. Nat Hum Behav 2:6\u201310. \n                    https:\/\/doi.org\/10.1038\/s41562-017-0189-z","journal-title":"Nat Hum Behav"},{"key":"1387_CR2","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(12)60361-4","volume":"379","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Stroes ES (2012) The interleukin-6 pathway and atherosclerosis. Lancet 379:1176\u20131178. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60361-4","journal-title":"Lancet"},{"key":"1387_CR3","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","volume":"114","author":"VJ Dzau","year":"2006","unstructured":"Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W (2006) The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 114:2850\u20132870. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.655688","journal-title":"Circulation"},{"key":"1387_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","volume":"74","author":"JA Fontes","year":"2015","unstructured":"Fontes JA, Rose NR, Cihakova D (2015) The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine 74:62\u201368. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2014.12.024","journal-title":"Cytokine"},{"key":"1387_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255\u2013265. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2014.28","journal-title":"Nat Rev Cardiol"},{"key":"1387_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijcard.2017.08.027","volume":"248","author":"HE Groot","year":"2017","unstructured":"Groot HE, Karper JC, Lipsic E, van Veldhuisen DJ, van der Horst ICC, van der Harst P (2017) High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction. Int J Cardiol 248:51\u201356. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.027","journal-title":"Int J Cardiol"},{"key":"1387_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1161\/01.CIR.0000065221.06430.ED","volume":"107","author":"JP Henriques","year":"2003","unstructured":"Henriques JP, Zijlstra F, van \u2018t Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H (2003) Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107:2115\u20132119. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000065221.06430.ED","journal-title":"Circulation"},{"key":"1387_CR8","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2013.06.044","volume":"62","author":"MV Holmes","year":"2013","unstructured":"Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M, Cooper JA, Palmen J, Hubacek JA, Carruthers KF, Horne BD, Brunisholz KD, Mega JL, van Iperen EPA, Li M, Leusink M, Trompet S, Verschuren JJW, Hovingh GK, Dehghan A, Nelson CP, Kotti S, Danchin N, Scholz M, Haase CL, Rothenbacher D, Swerdlow DI, Kuchenbaecker KB, Staines-Urias E, Goel A, van \u2018t Hooft F, Gertow K, de Faire U, Panayiotou AG, Tremoli E, Baldassarre D, Veglia F, Holdt LM, Beutner F, Gansevoort RT, Navis GJ, Mateo Leach I, Breitling LP, Brenner H, Thiery J, Dallmeier D, Franco-Cereceda A, Boer JMA, Stephens JW, Hofker MH, Tedgui A, Hofman A, Uitterlinden AG, Adamkova V, Pitha J, Onland-Moret NC, Cramer MJ, Nathoe HM, Spiering W, Klungel OH, Kumari M, Whincup PH, Morrow DA, Braund PS, Hall AS, Olsson AG, Doevendans PA, Trip MD, Tobin MD, Hamsten A, Watkins H, Koenig W, Nicolaides AN, Teupser D, Day INM, Carlquist JF, Gaunt TR, Ford I, Sattar N, Tsimikas S, Schwartz GG, Lawlor DA, Morris RW, Sandhu MS, Poledne R, Maitland-van der Zee AH, Khaw KT, Keating BJ, van der Harst P, Price JF, Mehta SR, Yusuf S, Witteman JCM, Franco OH, Jukema JW, de Knijff P, Tybjaerg-Hansen A, Rader DJ, Farrall M, Samani NJ, Kivimaki M, Fox KAA, Humphries SE, Anderson JL, Boekholdt SM, Palmer TM, Eriksson P, Par\u00e9 G, Hingorani AD, Sabatine MS, Mallat Z, Casas JP, Talmud PJ (2013) Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol 62:1966\u20131976. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.06.044","journal-title":"J Am Coll Cardiol"},{"key":"1387_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","volume":"379","author":"N Sarwar","year":"2012","unstructured":"IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP, Braund PS, Hall AS, Chasman DI, Tybjaerg-Hansen A, Chambers JC, Benjamin EJ, Franks PW, Clarke R, Wilde AA, Trip MD, Steri M, Witteman JC, Qi L, van der Schoot CE, de Faire U, Erdmann J, Stringham HM, Koenig W, Rader DJ, Melzer D, Reich D, Psaty BM, Kleber ME, Panagiotakos DB, Willeit J, Wennberg P, Woodward M, Adamovic S, Rimm EB, Meade TW, Gillum RF, Shaffer JA, Hofman A, Onat A, Sundstr\u00f6m J, Wassertheil-Smoller S, Mellstr\u00f6m D, Gallacher J, Cushman M, Tracy RP, Kauhanen J, Karlsson M, Salonen JT, Wilhelmsen L, Amouyel P, Cantin B, Best LG, Ben-Shlomo Y, Manson JE, Davey-Smith G, de Bakker PI, O\u2019Donnell CJ, Wilson JF, Wilson AG, Assimes TL, Jansson JO, Ohlsson C, Tivesten \u00c5, Ljunggren \u00d6, Reilly MP, Hamsten A, Ingelsson E, Cambien F, Hung J, Thomas GN, Boehnke M, Schunkert H, Asselbergs FW, Kastelein JJ, Gudnason V, Salomaa V, Harris TB, Kooner JS, Allin KH, Nordestgaard BG, Hopewell JC, Goodall AH, Ridker PM, H\u00f3lm H, Watkins H, Ouwehand WH, Samani NJ, Kaptoge S, Di Angelantonio E, Harari O, Danesh J (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379:1205\u20131213. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(11)61931-4","journal-title":"Lancet"},{"key":"1387_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"AD Hingorani","year":"2012","unstructured":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Hingorani AD, Casas JP (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379:1214\u20131224. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60110-X","journal-title":"Lancet"},{"key":"1387_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2009.03.033","volume":"206","author":"KA Kaminski","year":"2009","unstructured":"Kaminski KA, Kozuch M, Bonda T, Wojtkowska I, Kozieradzka A, Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Winnicka MM, Musial WJ (2009) Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction. Atherosclerosis 206:581\u2013587. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.03.033","journal-title":"Atherosclerosis"},{"key":"1387_CR12","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH, Espevik T, Aakhus S, Damas JK, Aukrust P, Wiseth R, Gullestad L (2016) Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J 37:2406\u20132413. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw171","journal-title":"Eur Heart J"},{"key":"1387_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10557-012-6413-1","volume":"26","author":"CP Lexis","year":"2012","unstructured":"Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ, GIPS-III Investigators (2012) Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial. Cardiovasc Drugs Ther 26:417\u2013426. \n                    https:\/\/doi.org\/10.1007\/s10557-012-6413-1","journal-title":"Cardiovasc Drugs Ther"},{"key":"1387_CR14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CP Lexis","year":"2014","unstructured":"Lexis CP, van der Horst IC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AF, van der Werf HW, Schurer RA, Pundziute G, Tas ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BH, van der Horst-Schrivers AN, Wolffenbuttel BH, ter Horst GJ, van ROssum AC, Tijdssen JG, Hillege HL, de Smet BJ, van der Harst P, van Veldhuisen DJ, GIPS-III Investigators (2014) Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA 311:1526\u20131535. \n                    https:\/\/doi.org\/10.1001\/jama.2014.3315","journal-title":"JAMA"},{"key":"1387_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129\u20132138. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2009.09.009","journal-title":"J Am Coll Cardiol"},{"key":"1387_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijcard.2018.02.062","volume":"259","author":"P Libby","year":"2018","unstructured":"Libby P, Rocha VZ (2018) All roads lead to IL-6: a central hub of cardiometabolic signaling. Int J Cardiol 259:213\u2013215. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2018.02.062","journal-title":"Int J Cardiol"},{"key":"1387_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lacellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277\u2013314. \n                    https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"1387_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors\/Task Force Members (2016) Document reviewers. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975. \n                    https:\/\/doi.org\/10.1002\/ejhf.592","journal-title":"Eur J Heart Fail"},{"key":"1387_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1054\/jcaf.2003.38","volume":"9","author":"M Puhakka","year":"2003","unstructured":"Puhakka M, Magga J, Hietakorpi S, Penttila I, Uusimaa P, Risteli J, Peuhkurinen K (2003) Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail 9:325\u2013332. \n                    https:\/\/doi.org\/10.1054\/jcaf.2003.38","journal-title":"J Card Fail"},{"key":"1387_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","volume":"118","author":"PM Ridker","year":"2016","unstructured":"Ridker PM (2016) From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res 118:145\u2013156. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306656","journal-title":"Circ Res"},{"key":"1387_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossie PRF, Torquay RPT, Libby P, Glynn RJ, CANTOS Trial Group (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"1387_CR22","doi-asserted-by":"publisher","unstructured":"Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GO (2016) Circulating levels of IL-6 receptor and gp130 and long-term clinical outcomes in ST-elevation myocardial infarction. J Am Heart Assoc 5:\n                    https:\/\/doi.org\/10.1161\/JAHA.115.003014","DOI":"10.1161\/JAHA.115.003014"},{"key":"1387_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.rinim.2013.11.002","volume":"4","author":"VN Ritschel","year":"2013","unstructured":"Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GO (2013) IL-6 signalling in patients with acute ST-elevation myocardial infarction. Results Immunol 4:8\u201313. \n                    https:\/\/doi.org\/10.1016\/j.rinim.2013.11.002","journal-title":"Results Immunol"},{"key":"1387_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0022-5223(98)70018-2","volume":"116","author":"Y Sawa","year":"1998","unstructured":"Sawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H (1998) Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116:511\u2013517. \n                    https:\/\/doi.org\/10.1016\/S0022-5223(98)70018-2","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1387_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878\u2013888. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"key":"1387_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/164_2016_86","volume":"243","author":"M Senni","year":"2017","unstructured":"Senni M, D\u2019Elia E, Emdin M, Vergaro G (2017) Biomarkers of heart failure with preserved and reduced ejection fraction. Handb Exp Pharmacol 243:79\u2013108. \n                    https:\/\/doi.org\/10.1007\/164_2016_86","journal-title":"Handb Exp Pharmacol"},{"key":"1387_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11239-016-1390-z","volume":"42","author":"S Diepen van","year":"2016","unstructured":"van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, Mahaffey KW, Granger CB, Armstrong PW (2016) Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction. J Thromb Thrombolysis 42:376\u2013385. \n                    https:\/\/doi.org\/10.1007\/s11239-016-1390-z","journal-title":"J Thromb Thrombolysis"},{"key":"1387_CR28","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","volume":"97","author":"AW Hof van \u2018t","year":"1998","unstructured":"van \u2018t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F (1998) Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97:2302\u20132306. \n                    https:\/\/doi.org\/10.1161\/01.CIR.97.23.2302","journal-title":"Circulation"},{"key":"1387_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410\u20131422. \n                    https:\/\/doi.org\/10.1038\/nm.2538","journal-title":"Nat Med"},{"key":"1387_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","volume":"148","author":"JS Yudkin","year":"2000","unstructured":"Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209\u2013214. \n                    https:\/\/doi.org\/10.1016\/S0021-9150(99)00463-3","journal-title":"Atherosclerosis"},{"key":"1387_CR31","doi-asserted-by":"publisher","first-page":"e003103","DOI":"10.1161\/JAHA.112.003103","volume":"2","author":"P Zamani","year":"2013","unstructured":"Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P, Kinlay S (2013) Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study investigators. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2:e003103. \n                    https:\/\/doi.org\/10.1161\/JAHA.112.003103","journal-title":"J Am Heart Assoc"},{"key":"1387_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1042\/CS20100385","volume":"120","author":"H Zhu","year":"2011","unstructured":"Zhu H, Belcher M, van der Harst P (2011) Healthy aging and disease: role for telomere biology? Clin Sci (Lond) 120:427\u2013440. \n                    https:\/\/doi.org\/10.1042\/CS20100385","journal-title":"Clin Sci (Lond)"},{"key":"1387_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy191","author":"L Ziegler","year":"2018","unstructured":"Ziegler L, Gajulapuri A, Frumento P, Bonomi A, Wallen H, de Faire U, Rose-John S, Gigante B (2018) Interleukin 6 trans-signalling and risk of future cardiovascular events. Cardiovasc Res. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvy191\n                    \n                  \n                           (Epub ahead of print)","journal-title":"Cardiovasc Res"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1387-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T21:04:48Z","timestamp":1572037488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1387-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1387-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol of the GIPS-III trial was in accordance with the Declaration of Helsinki and was approved by the local ethics committee (Groningen, the Netherlands) and national regulatory authorities. Informed consent was obtained for inclusion of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}